Please try another search
Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company’s product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. Infinity Pharmaceuticals, Inc. has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Cambridge, Massachusetts. On September 29, 2023, Infinity Pharmaceuticals, Inc. along with its affiliate, a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on March 7, 2024.
Name | Age | Since | Title |
---|---|---|---|
Anthony B. Evnin | 82 | 2006 | Independent Director |
Dmitry I. Gabrilovich | - | 2018 | Member of Scientific Advisory Board |
David William Beier | 74 | 2018 | Independent Director |
Norman C. Selby | 71 | 2012 | Lead Independent Director |
F. Stephen Hodi | - | 2018 | Member of Scientific Advisory Board |
Jeffery L. Kutok | 56 | 2017 | Chairman of Scientific Advisory Board |
Samuel Agresta | 50 | 2018 | Chair of Clinical Advisory Board |
David H. Munn | - | 2018 | Member of Scientific Advisory Board |
Roy Steven Herbst | 60 | 2018 | Member of Scientific Advisory Board |
Padmanee Sharma | - | - | Member of Clinical Advisory Board |
Michael Postow | - | - | Member of Clinical Advisory Board |
Toni K. Choueiri | - | - | Member of Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review